Soy Isoflavones and Cancer Prevention

Cancer Investigation

Volumn 21, Issue 5, 2003, Pages 744-757

  Sarkar, Fazlul H ^a   Li, Yiwei ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Chemoprevention; Soy isoflavones

Indexed keywords

ANDROGEN; ESTROGEN; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PROTEIN KINASE B;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASIA; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CHEMICAL STRUCTURE; CHINA; DIET; ETHNIC GROUP; EUROPE; GENE CONTROL; HOMEOSTASIS; HUMAN; JAPAN; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; SOYBEAN; UNITED STATES;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; CHEMOPREVENTION; GENISTEIN; HUMANS; ISOFLAVONES; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 0242496947     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120023773     Document Type: Review

References (117)

1. Kelloff, G.J.; Boone, C.W.; Steele, V.E.; Fay, J.R.; Lubet, R.A.; Crowell, J.A.; Sigman, C.C. Mechanistic considerations in chemopreventive drug development. J. Cell Biochem. Suppl. 1994, 20, 1-24.
2. Adlercreutz, C.H.; Goldin, B.R.; Gorbach, S.L.; Hockerstedt, K.A.; Watanabe, S.; Hamalainen, E.K.; Markkanen, M.H.; Makela, T.H.; Wahala, K.T.; Adlercreutz, T. Soybean phytoestrogen intake and cancer risk. J. Nutr. 1995, 125 (3 Suppl.), 757S-770S.
3. Hebert, J.R.; Hurley, T.G.; Olendzki, B.C.; Teas, J.; Ma, Y.; Hampl, J.S. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J. Natl. Cancer Inst. 1998, 90 (21), 1637-1647.
4. Adlercreutz, H.; Honjo, H.; Higashi, A.; Fotsis, T.; Hamalainen, E.; Hasegawa, T.; Okada, H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 1991, 54 (6), 1093-1100.
5. Lee, H.P.; Gourley, L.; Duffy, S.W.; Esteve, J.; Lee, J.; Day, N.E. Dietary effects on breast-cancer risk in Singapore. Lancet 1991, 337 (8751), 1197-1200.
6. Jacobsen, B.K.; Knutsen, S.F.; Fraser, G.E. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 1998, 9 (6), 553-557.
7. Adlercreutz, H.; Markkanen, H.; Watanabe, S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993, 342 (8881), 1209-1210.
8. Mills, P.K.; Beeson, W.L.; Phillips, R.L.; Fraser, G.E. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989, 64 (3), 598-604.
9. Kumar, N.B.; Cantor, A.; Allen, K.; Riccardi, D.; Cox, C.E. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 2002, 94, 1166-1174.
10. Li, Y.; Upadhyay, S.; Bhuiyan, M.; Sarkar, F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999, 18 (20), 3166-3172.
11. Li, Y.; Bhuiyan, M.; Sarkar, F.H. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int. J. Oncol. 1999, 15 (3), 525-533.
12. Lian, F.; Bhuiyan, M.; Li, Y.W.; Wall, N.; Kraut, M.; Sarkar, F.H. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr. Cancer 1998, 31 (3), 184-191.
13. Alhasan, S.A.; Pietrasczkiwicz, H.; Alonso, M.D.; Ensley, J.; Sarkar, F.H. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr. Cancer 1999, 34 (1), 12-19.
14. Upadhyay, S.; Neburi, M.; Chinni, S.R.; Alhasan, S.; Miller, F.; Sarkar, F.H. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clin. Cancer Res. 2001, 7 (6), 1782-1789.
15. Spinozzi, F.; Pagliacci, M.C.; Migliorati, G.; Moraca, R.; Grignani, F.; Riccardi, C.; Nicoletti, I. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk. Res. 1994, 18 (6), 431-439.
16. Constantinou, A.; Huberman, E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med. 1995, 208 (1), 109-115.
17. Davis, J.N.; Singh, B.; Bhuiyan, M.; Sarkar, F.H. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr. Cancer 1998, 32 (3), 123-131.
18. Messina, M.J. J. Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin. Nutr. 1999, 70 (3 Suppl.), 439S-450S.
19. Knight, D.C.; Eden, J.A. A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 1996, 2 (5 Pt 2), 897-904.
20. Zava, D.T.; Dollbaum, C.M.; Blen, M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 1998, 217 (3), 369-378.
21. Martin, P.M.; Horwitz, K.B.; Ryan, D.S.; McGuire, W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978, 103 (5), 1860-1867.
22. Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; van der Saag, P.T.; van der, B.B.; Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139 (10), 4252-4263.
23. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262 (12), 5592-5595.
24. Hunter, T. A thousand and one protein kinases. Cell 1987, 50 (6), 823-829.
25. Ullrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61 (2), 203-212.
26. Okura, A.; Arakawa, H.; Oka, H.; Yoshinari, T.; Monden, Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 1988, 157 (1), 183-189.
27. Evans, B.A.; Griffiths, K.; Morton, M.S. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 1995, 147 (2), 295-302.
28. Huang, J.; Nasr, M.; Kim, Y.; Matthews, H.R. Genistein inhibits protein histidine kinase. J. Biol. Chem. 1992, 267 (22), 15511-15515.
29. Ruiz-Larrea, M.B.; Mohan, A.R.; Paganga, G.; Miller, N.J.; Bolwell, G.P. ; Rice-Evans, C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 1997, 26 (1), 63-70.
30. Zhou, Y.; Lee, A.S. Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J. Natl. Cancer Inst. 1998, 90 (5), 381-388.
31. Wu, M.; Lee, H.; Bellas, R.E.; Schauer, S.L.; Arsura, M.; Katz, D.; FitzGerald, M.J.; Rothstein, T.L.; Sherr, D.H.; Sonenshein, G.E. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 1996, 15 (17), 4682-4690.
32. Van Antwerp, D.J.; Martin, S.J.; Kafri, T.; Green, D.R.; Verma, I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274 (5288), 787-789.
33. Cardone, M.H.; Roy, N.; Stennicke, H.R.; Salvesen, G.S.; Franke, T.F.; Stanbridge, E.; Frisch, S.; Reed, J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282 (5392), 1318-1321.
34. Brunet, A.; Bonni, A.; Zigmond, M.J.; Lin, M.Z.; Juo, P.; Hu, L.S.; Anderson, M.J.; Arden, K.C.; Blenis, J.; Greenberg, M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96 (6), 857-868.
35. Sharma, O.P.; Adlercreutz, H.; Strandberg, J.D.; Zirkin, B.R.; Coffey, D.S.; Ewing, L.L. Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J. Steroid Biochem. Mol. Biol. 1992, 43 (6), 557-564.
36. Onozawa, M.; Kawamori, T.; Baba, M.; Fukuda, K.; Toda, T.; Sato, H.; Ohtani, M.; Akaza, H.; Sugimura, T.; Wakabayashi, K. Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Jpn J. Cancer Res. 1999, 90 (4), 393-398.
37. Landstrom, M.; Zhang, J.X.; Hallmans, G.; Aman, P.; Bergh, A.; Damber, J.E.; Mazur, W.; Wahala, K.; Adlercreutz, H. Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 1998, 36 (3), 151-161.
38. Zhou, J.R.; Gugger, E.T.; Tanaka, T.; Guo, Y.; Blackburn, G.L.; Clinton, S.K. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 1999, 129 (9), 1628-1635.
39. Lamartiniere, C.A.; Moore, J.B.; Brown, N.M.; Thompson, R.; Hardin, M.J. ; Barnes, S. Genistein suppresses mammary cancer in rats. Carcinogenesis 1995, 16 (11), 2833-2840.
40. Uckun, F.M.; Evans, W.E.; Forsyth, C.J.; Waddick, K.G.; Ahlgren, L.T.; Chelstrom, L.M.; Burkhardt, A.; Bolen, J.; Myers, D.E. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995, 267 (5199), 886-891.
41. Barnes, S.; Peterson, T.G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med. 1995, 208 (1), 103-108.
42. Barnes, S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 1995, 125 (3 Suppl.), 777S-783S.
43. Matsukawa, Y.; Marui, N.; Sakai, T.; Satomi, Y.; Yoshida, M.; Matsumoto, K.; Nishino, H.; Aoike, A. Genistein arrests cell cycle progression at G2-M. Cancer Res. 1993, 53 (6), 1328-1331.
44. Casagrande, F.; Darbon, J.M. p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp. Cell Res. 2000, 258 (1), 101-108.
45. Pagliacci, M.C.; Smacchia, M.; Migliorati, G.; Grignani, F.; Riccardi, C.; Nicoletti, I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer 1994, 30A (11), 1675-1682.
46. Kuzumaki, T.; Kobayashi, T.; Ishikawa, K. Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem. Biophys. Res. Commun. 1998, 251 (1), 291-295.
47. Lian, F.; Li, Y.; Bhuiyan, M.; Sarkar, F.H. p53-Independent apoptosis induced by genistein in lung cancer cells. Nutr. Cancer 1999, 33 (2), 125-131.
48. Alhasan, S.A.; Ensley, J.F.; Sarkar, F.H. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int. J. Oncol. 2000, 16 (2), 333-338.
49. Chiarugi, V.; Magnelli, L.; Cinelli, M.; Basi, G. Apoptosis and the cell cycle. Cell Mol. Biol. Res. 1994, 40 (7-8), 603-612.
50. Huang, P.; Ballal, K.; Plunkett, W. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis. Cancer Res. 1997, 57 (16), 3407-3414.
51. Fisher, D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 1994, 78 (4), 539-542.
52. Lazebnik, Y.A.; Kaufmann, S.H.; Desnoyers, S.; Poirier, G.G.; Earnshaw, W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371 (6495), 346-347.
53. Tewari, M.; Quan, L.T.; O'Rourke, K.; Desnoyers, S.; Zeng, Z.; Beidler, D.R.; Poirier, G.G.; Salvesen, G.S.; Dixit, V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995, 81 (5), 801-809.
54. Darmon, A.J.; Nicholson, D.W.; Bleackley, R.C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995, 377 (6548), 446-448.
55. Philpott, N.J.; Turner, A.J.; Scopes, J.; Westby, M.; Marsh, J.C.; Gordon-Smith, E.C.; Dalgleish, A.G.; Gibson, F.M. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 1996, 87 (6), 2244-2251.
56. Kyle, E.; Neckers, L.; Takimoto, C.; Curt, G.; Bergan, R. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol. Pharmacol. 1997, 51 (2), 193-200.
57. Park, J.R.; Hockenbery, D.M. BCL-2, a novel regulator of apoptosis. J. Cell Biochem. 1996, 60 (1), 12-17.
58. Findley, H.W.; Gu, L.; Yeager, A.M.; Zhou, M. Expression and regulation of Bcl-2 Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997, 89 (8), 2986-2993.
59. Kane, D.J.; Sarafian, T.A.; Anton, R.; Hahn, H.; Gralla, E.B.; Valentine, J.S.; Ord, T.; Bredesen, D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993, 262 (5137), 1274-1277.
60. Vogelstein, B.; Kinzler, K.W. p53 Function and dysfunction. Cell 1992, 70 (4), 523-526.
61. el Deiry, W.S.; Tokino, T.; Velculescu, V.E.; Levy, D.B.; Parsons, R.; Trent, J.M.; Lin, D.; Mercer, W.E.; Kinzler, K.W.; Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75 (4), 817-825.
62. Harper, J.W.; Adami, G.R.; Wei, N.; Keyomarsi, K.; Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75 (4), 805-816.
63. Agarwal, M.L.; Agarwal, A.; Taylor, W.R.; Stark, G.R. p53 Controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (18), 8493-8497.
64. Xiong, Y.; Hannon, G.J.; Zhang, H.; Casso, D.; Kobayashi, R.; Beach, D. p21 Is a universal inhibitor of cyclin kinases. Nature 1993, 366 (6456), 701-704.
65. Shao, Z.M.; Alpaugh, M.L.; Fontana, J.A.; Barsky, S.H. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J. Cell Biochem. 1998, 69 (1), 44-54.
66. Wang, T.T.; Sathyamoorthy, N.; Phang, J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996, 17 (2), 271-275.
67. Wang, C.; Kurzer, M.S. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer 1997, 28 (3), 236-247.
68. Verma, I.M.; Stevenson, J.K.; Schwarz, E.M.; Van Antwerp, D.; Miyamoto, S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 1995, 9 (22), 2723-2735.
69. Thanos, D.; Maniatis, T. NF-kappa B.: A lesson in family values. Cell 1995, 80 (4), 529-532.
70. Ghosh, G.; van Duyne, G.; Ghosh, S.; Sigler, P.B. Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature 1995, 373 (6512), 303-310.
71. Muller, C.W.; Rey, F.A.; Sodeoka, M.; Verdine, G.L.; Harrison, S.C. Structure of the NF-kappa B p50 homodimer bound to DNA. Nature 1995, 373 (6512), 311-317.
72. Chen, Z.J.; Parent, L.; Maniatis, T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996, 84 (6), 853-862.
73. Chen, Z.; Hagler, J.; Palombella, V.J.; Melandri, F.; Scherer, D.; Ballard, D.; Maniatis, T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995, 9 (13), 1586-1597.
74. Traenckner, E.B.; Pahl, H.L.; Henkel, T.; Schmidt, K.N.; Wilk, S.; Baeuerle, P.A. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 1995, 14 (12), 2876-2883.
75. Pahl, H.L.; Baeuerle, P.A. Control of gene expression by proteolysis. Curr. Opin. Cell Biol. 1996, 8 (3), 340-347.
76. Lenardo, M.J.; Baltimore, D. NF-kappa B.: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58 (2), 227-229.
77. Baldwin, A.S., Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649-683.
78. Beg, A.A.; Baltimore, D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274 (5288), 782-784.
79. Wang, C.Y.; Mayo, M.W.; Korneluk, R.G.; Goeddel, D.V.; Baldwin, A.S., Jr. NF-kappaB anti-apoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281 (5383), 1680-1683.
80. Beg, A.A.; Sha, W.C.; Bronson, R.T.; Ghosh, S.; Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376 (6536), 167-170.
81. Davis, J.N.; Kucuk, O.; Sarkar, F.H. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr. Cancer 1999, 35 (2), 167-174.
82. Brown, K.; Gerstberger, S.; Carlson, L.; Franzoso, G.; Siebenlist, U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995, 267 (5203), 1485-1488.
83. Zandi, E.; Chen, Y.; Karin, M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 1998, 281 (5381), 1360-1363.
84. Karin, M.; Delhase, M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 2000, 12 (1), 85-98.
85. Lee, F.S.; Peters, R.T.; Dang, L.C.; Maniatis, T. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (16), 9319-9324.
86. Nakano, H.; Shindo, M.; Sakon, S.; Nishinaka, S.; Mihara, M.; Yagita, H. ; Okumura, K. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (7), 3537-3542.
87. Franke, T.F.; Kaplan, D.R.; Cantley, L.C. PI3K: downstream AKTion blocks apoptosis. Cell 1997, 88 (4), 435-437.
88. Burgering, B.M.; Coffer, P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376 (6541), 599-602.
89. Franke, T.F.; Yang, S.I.; Chan, T.O.; Datta, K.; Kazlauskas, A.; Morrison, D.K.; Kaplan, D.R.; Tsichlis, P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81 (5), 727-736.
90. Alessi, D.R.; Andjelkovic, M.; Caudwell, B.; Cron, P.; Morrice, N.; Cohen, P.; Hemmings, B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15 (23), 6541-6551.
91. Rommel, C.; Clarke, B.A.; Zimmermann, S.; Nunez, L.; Rossman, R.; Reid, K.; Moelling, K.; Yancopoulos, G.D.; Glass, D.J. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999, 286 (5445), 1738-1741.
92. Romashkova, J.A.; Makarov, S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401 (6748), 86-90.
93. Ozes, O.N.; Mayo, L.D.; Gustin, J.A.; Pfeffer, S.R.; Pfeffer, L.M.; Donner, D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401 (6748), 82-85.
94. Li, Y.; Sarkar, F.H. Inhibition of NF-kB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin. Cancer Res. 2002, 8 (7), 2369-2317.
95. Montgomery, J.S.; Price, D.K.; Figg, W.D. The androgen receptor gene and its influence on the development and progression of prostate cancer. J. Pathol. 2001, 195 (2), 138-146.
96. Kupelian, P.; Katcher, J.; Levin, H.; Zippe, C.; Klein, E. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 1996, 48 (2), 249-260.
97. Sato, N.; Gleave, M.E.; Bruchovsky, N.; Rennie, P.S.; Goldenberg, S.L.; Lange, P.H.; Sullivan, L.D. Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model. J. Steroid Biochem. Mol. Biol. 1996, 58 (2), 139-146.
98. Luke, M.C.; Coffey, D.S. Human androgen receptor binding to the androgen response element of prostate specific antigen. J. Androl. 1994, 15 (1), 41-51.
99. Davis, J.N.; Muqim, N.; Bhuiyan, M.; Kucuk, O.; Pienta, K.J.; Sarkar, F.H. Inhibition of prostate specific antigen expression by genistein in prostate cancer cells. Int. J. Oncol. 2000, 16 (6), 1091-1097.
100. Davis, J.N.; Kucuk, O.; Sarkar, H.F. Expression of prostate specific antigen (PSA) is transcriptionally regulated by genistein in prostate cancer cells. Mol. Carcinog. 2002, (in press).
101. Fritz, W.A.; Wang, J.; Eltoum, I.E.; Lamartiniere, C.A. Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol. Cell Endocrinol. 2002, 186 (1), 89-99.
102. Kumar, R.; Yarmand-Bagheri, R. The role of HER2 in angiogenesis. Semin. Oncol. 2001, 28 (5 Suppl. 16), 27-32.
103. Yu, D.; Hung, M.C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 2000, 19 (53), 6115-6121.
104. Himelstein, B.P.; Canete-Soler, R.; Bernhard, E.J.; Dilks, D.W.; Muschel, R.J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994, 14 (1-6), 246-258.
105. Saaristo, A.; Karpanen, T.; Alitalo, K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000, 19 (53), 6122-6129.
106. Andreasen, P.A.; Kjoller, L.; Christensen, L.; Duffy, M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 1997, 72 (1), 1-22.
107. Bikfalvi, A. Significance of angiogenesis in tumour progression and metastasis. Eur. J. Cancer 1995, 31A (7-8), 1101-1104.
108. Fotsis, T.; Pepper, M.; Adlercreutz, H.; Hase, T.; Montesano, R.; Schweigerer, L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 1995, 125 (3 Suppl.), 790S-797S.
109. Li, D.; Yee, J.A.; McGuire, M.H.; Murphy, P.A.; Yan, L. Soybean isoflavones reduce experimental metastasis in mice. J. Nutr. 1999, 129 (5), 1075-1078.
110. Tan, M.; Yao, J.; Yu, D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 1997, 57 (6), 1199-1205.
111. Alhasan, S.A.; Aranha, O.; Sarkar, F.H. Genistein elicits pleiotropic molecular effects on head and neck cancer cells. Clin. Cancer Res. 2001, 7 (12), 4174-4181.
112. Li, Y.; Sarkar, F.H. Gene expression profile of PC3 prostate cancer cells exposed to genistein revealed novel molecular pathways for therapeutic intervention. AACR 93rd Annual Meeting 2002, LB-141 (Proceedings Supplement), 81
113. Wei, H.; Wei, L.; Frenkel, K.; Bowen, R.; Barnes, S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer 1993, 20 (1), 1-12.
114. Kameoka, S.; Leavitt, P.; Chang, C.; Kuo, S.M. Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1999, 146 (2), 161-167.
115. Toledano, M.B.; Leonard, W.J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U.S.A. 1991, 88 (10), 4328-4332.
116. Dudek, E.J.; Shang, F.; Taylor, A. H(2)O(2)-mediated oxidative stress activates NF-kappa B in lens epithelial cells. Free Radic. Biol. Med. 2001, 31 (5), 651-658.
117. Davis, J.N.; Kucuk, O.; Djuric, Z.; Sarkar, F.H. Soy isoflavone supplementation in healthy men prevents NF-kappaB activation by TNF-alpha in blood lymphocytes. Free Radic. Biol. Med. 2001, 30 (11), 1293-1302.